ABVC BioPharma
ABVC on XNAS, ABVC BioPharma, Inc.
Measures activity, not value. Not investment advice.
Shares sold short (30 Oct 2026)
603K
+2.2% vs the report before
Short interest, % of shares outstanding
2.2%
27.0M shares outstanding (9 Nov 2026)
Days to cover
19.9
short interest / daily volume
Short sale volume share (20 Nov 2026)
22%
1-year median 25%
Sharp changes
6
short interest spike
FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.
See the numbers
| 30 Oct 2026: 603K shares sold short, 19.9 days to cover |
| 15 Oct 2026: 590K shares sold short, 6.9 days to cover |
| 30 Sep 2026: 490K shares sold short, 3.6 days to cover |
| 15 Sep 2026: 505K shares sold short, 3.8 days to cover |
| 31 Aug 2026: 525K shares sold short, 5.5 days to cover |
| 14 Aug 2026: 429K shares sold short, 3.5 days to cover |
| 31 Jul 2026: 442K shares sold short, 5.6 days to cover |
| 15 Jul 2026: 465K shares sold short, 1.8 days to cover |
| 30 Jun 2026: 367K shares sold short, 2.1 days to cover |
| 15 Jun 2026: 391K shares sold short, 3.5 days to cover |
| 29 May 2026: 259K shares sold short, 1.8 days to cover |
| 15 May 2026: 273K shares sold short, 3.5 days to cover |
| 30 Apr 2026: 258K shares sold short, 3.8 days to cover |
| 15 Apr 2026: 295K shares sold short, 1.3 days to cover |
| 31 Mar 2026: 265K shares sold short, 4.7 days to cover |
| 13 Mar 2026: 248K shares sold short, 3.9 days to cover |
| 27 Feb 2026: 247K shares sold short, 5.6 days to cover |
| 13 Feb 2026: 248K shares sold short, 4.0 days to cover |
| 30 Jan 2026: 251K shares sold short, 4.9 days to cover |
| 15 Jan 2026: 343K shares sold short, 6.7 days to cover |
| 31 Dec 2025: 347K shares sold short, 4.3 days to cover |
| 15 Dec 2025: 366K shares sold short, 4.8 days to cover |
| 28 Nov 2025: 377K shares sold short, 6.6 days to cover |
| 14 Nov 2025: 386K shares sold short, 6.0 days to cover |
| 31 Oct 2025: 391K shares sold short, 6.3 days to cover |
| 15 Oct 2025: 428K shares sold short, 4.2 days to cover |
| 30 Sep 2025: 636K shares sold short, 5.8 days to cover |
| 15 Sep 2025: 651K shares sold short, 8.5 days to cover |
| 29 Aug 2025: 701K shares sold short, 5.9 days to cover |
| 15 Aug 2025: 706K shares sold short, 3.7 days to cover |
| 31 Jul 2025: 618K shares sold short, 2.3 days to cover |
| 15 Jul 2025: 568K shares sold short, 1.0 days to cover |
| 30 Jun 2025: 645K shares sold short, 1.5 days to cover |
| 13 Jun 2025: 507K shares sold short, 1.5 days to cover |
| 30 May 2025: 451K shares sold short, 1.7 days to cover |
| 15 May 2025: 444K shares sold short, 1.4 days to cover |
| 30 Apr 2025: 317K shares sold short, 1.7 days to cover |
| 15 Apr 2025: 255K shares sold short, 1.0 days to cover |
| 31 Mar 2025: 288K shares sold short, 1.8 days to cover |
| 14 Mar 2025: 321K shares sold short, 1.9 days to cover |
| 28 Feb 2025: 416K shares sold short, 1.0 days to cover |
| 14 Feb 2025: 258K shares sold short, 2.1 days to cover |
| 31 Jan 2025: 220K shares sold short, 2.6 days to cover |
| 15 Jan 2025: 293K shares sold short, 2.0 days to cover |
| 31 Dec 2024: 360K shares sold short, 2.2 days to cover |
| 13 Dec 2024: 628K shares sold short, 1.0 days to cover |
| 29 Nov 2024: 253K shares sold short, 3.5 days to cover |
| 15 Nov 2024: 334K shares sold short, 2.4 days to cover |
| 31 Oct 2024: 186K shares sold short, 1.0 days to cover |
| 15 Oct 2024: 138K shares sold short, 1.0 days to cover |
| 30 Sep 2024: 132K shares sold short, 3.1 days to cover |
| 13 Sep 2024: 111K shares sold short, 3.8 days to cover |
| 30 Aug 2024: 138K shares sold short, 3.1 days to cover |
| 15 Aug 2024: 127K shares sold short, 2.3 days to cover |
| 31 Jul 2024: 180K shares sold short, 1.0 days to cover |
| 15 Jul 2024: 163K shares sold short, 2.9 days to cover |
| 28 Jun 2024: 228K shares sold short, 1.9 days to cover |
| 14 Jun 2024: 370K shares sold short, 2.8 days to cover |
| 31 May 2024: 435K shares sold short, 2.3 days to cover |
| 15 May 2024: 588K shares sold short, 1.2 days to cover |
What the numbers say
- 603K shares sold short on 30 Oct 2026, 2.2% of shares outstanding, 19.9 days to cover; +2.2% on the report before, the most since Sep 2025 (published by FINRA on 10 Nov 2026).
Every measure from this source
Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.
Sharp changes
6 in all loaded history, strongest first
ABVC BioPharma had 1.3M shares sold short in the 28 Mar 2024 report, 11× the same report last year.
Same report last year: 121K; its normal report is 108K.
See the evidence
- This period
- 1.3M (the 28 Mar 2024 report)
- Normal report (median of 24 earlier)
- 108K
- Typical spread (median absolute deviation)
- 38K
- How far from its usual level
- +21.4
- Same report last year
- 121K
- History used
- 2,052 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
ABVC BioPharma had 984K shares sold short in the 31 Oct 2023 report, 60× the same report last year.
Same report last year: 16K; its normal report is 79K.
See the evidence
- This period
- 984K (the 31 Oct 2023 report)
- Normal report (median of 24 earlier)
- 79K
- Typical spread (median absolute deviation)
- 49K
- How far from its usual level
- +12.5
- Same report last year
- 16K
- History used
- 1,903 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
ABVC BioPharma had 638K shares sold short in the 30 Apr 2024 report, 3.9× the same report last year.
Same report last year: 163K; its normal report is 108K.
See the evidence
- This period
- 638K (the 30 Apr 2024 report)
- Normal report (median of 24 earlier)
- 108K
- Typical spread (median absolute deviation)
- 52K
- How far from its usual level
- +6.8
- Same report last year
- 163K
- History used
- 2,085 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
ABVC BioPharma had 628K shares sold short in the 13 Dec 2024 report, 13× the same report last year.
Same report last year: 47K; its normal report is 157K.
See the evidence
- This period
- 628K (the 13 Dec 2024 report)
- Normal report (median of 24 earlier)
- 157K
- Typical spread (median absolute deviation)
- 49K
- How far from its usual level
- +6.5
- Same report last year
- 47K
- History used
- 2,312 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
ABVC BioPharma had 533K shares sold short in the 15 Apr 2024 report, 4.8× the same report last year.
Same report last year: 112K; its normal report is 108K.
See the evidence
- This period
- 533K (the 15 Apr 2024 report)
- Normal report (median of 24 earlier)
- 108K
- Typical spread (median absolute deviation)
- 47K
- How far from its usual level
- +6.1
- Same report last year
- 112K
- History used
- 2,070 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
ABVC BioPharma had 588K shares sold short in the 15 May 2024 report, 4.4× the same report last year.
Same report last year: 135K; its normal report is 108K.
See the evidence
- This period
- 588K (the 15 May 2024 report)
- Normal report (median of 24 earlier)
- 108K
- Typical spread (median absolute deviation)
- 56K
- How far from its usual level
- +5.8
- Same report last year
- 135K
- History used
- 2,100 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.